These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 25527055

  • 1. EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1.
    van Asselt SJ, Brouwers AH, van Dullemen HM, van der Jagt EJ, Bongaerts AH, Kema IP, Koopmans KP, Valk GD, Timmers HJ, de Herder WW, Feelders RA, Fockens P, Sluiter WJ, de Vries EG, Links TP.
    Gastrointest Endosc; 2015 Jan; 81(1):159-167.e2. PubMed ID: 25527055
    [Abstract] [Full Text] [Related]

  • 2. Potential value of EUS in pancreatic surveillance of VHL patients.
    van Asselt SJ, Brouwers AH, van Dullemen HM, van der Jagt EJ, Bongaerts AH, Koopmans KP, Kema IP, Zonnenberg BA, Timmers HJ, de Herder WW, Sluiter WJ, de Vries EG, Links TP.
    Eur J Endocrinol; 2016 May; 174(5):611-20. PubMed ID: 26884551
    [Abstract] [Full Text] [Related]

  • 3. Utility of FDG-PET Imaging for Risk Stratification of Pancreatic Neuroendocrine Tumors in MEN1.
    Kornaczewski Jackson ER, Pointon OP, Bohmer R, Burgess JR.
    J Clin Endocrinol Metab; 2017 Jun 01; 102(6):1926-1933. PubMed ID: 28323985
    [Abstract] [Full Text] [Related]

  • 4. Natural course of small, asymptomatic neuroendocrine pancreatic tumours in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study.
    Kann PH, Balakina E, Ivan D, Bartsch DK, Meyer S, Klose KJ, Behr T, Langer P.
    Endocr Relat Cancer; 2006 Dec 01; 13(4):1195-202. PubMed ID: 17158764
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of (68)Ga-DOTA-TOC PET/CT for the detection of duodenopancreatic neuroendocrine tumors in patients with MEN1.
    Morgat C, Vélayoudom-Céphise FL, Schwartz P, Guyot M, Gaye D, Vimont D, Schulz J, Mazère J, Nunes ML, Smith D, Hindié E, Fernandez P, Tabarin A.
    Eur J Nucl Med Mol Imaging; 2016 Jul 01; 43(7):1258-66. PubMed ID: 26819103
    [Abstract] [Full Text] [Related]

  • 6. Magnetic Resonance Imaging or Endoscopic Ultrasonography for Detection and Surveillance of Pancreatic Neuroendocrine Neoplasms in Patients with Multiple Endocrine Neoplasia Type 1?
    Daskalakis K, Tsoli M, Alexandraki KI, Angelousi A, Chatzellis E, Tsolakis AV, Karoumpalis I, Kolomodi D, Kassi E, Kaltsas G.
    Horm Metab Res; 2019 Sep 01; 51(9):580-585. PubMed ID: 31295747
    [Abstract] [Full Text] [Related]

  • 7. Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.
    Koopmans KP, Neels OC, Kema IP, Elsinga PH, Sluiter WJ, Vanghillewe K, Brouwers AH, Jager PL, de Vries EG.
    J Clin Oncol; 2008 Mar 20; 26(9):1489-95. PubMed ID: 18349401
    [Abstract] [Full Text] [Related]

  • 8. Rupture of small cystic pancreatic neuroendocrine tumor with many microtumors.
    Sagami R, Nishikiori H, Ikuyama S, Murakami K.
    World J Gastroenterol; 2017 Oct 07; 23(37):6911-6919. PubMed ID: 29085235
    [Abstract] [Full Text] [Related]

  • 9. Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography.
    Orlefors H, Sundin A, Garske U, Juhlin C, Oberg K, Skogseid B, Langstrom B, Bergstrom M, Eriksson B.
    J Clin Endocrinol Metab; 2005 Jun 07; 90(6):3392-400. PubMed ID: 15755858
    [Abstract] [Full Text] [Related]

  • 10. Magnetic resonance imaging versus endoscopic ultrasonography for the detection of pancreatic tumours in multiple endocrine neoplasia type 1.
    Barbe C, Murat A, Dupas B, Ruszniewski P, Tabarin A, Vullierme MP, Penfornis A, Rohmer V, Baudin E, Le Rhun M, Gaye D, Marcus C, Cadiot G, Groupe d’étude des Tumeurs Endocrines (GTE).
    Dig Liver Dis; 2012 Mar 07; 44(3):228-34. PubMed ID: 22078814
    [Abstract] [Full Text] [Related]

  • 11. Comparison of 68Ga-Dotatate PET/CT and 18F-FDOPA PET/CT for the diagnosis of pancreatic neuroendocrine tumors in a MEN1 patient.
    Jullien M, Reichert T, D'Anella P, Castinetti F, Barlier A, Brue T, Taieb D, Cuny T.
    Ann Endocrinol (Paris); 2020 Feb 07; 81(1):39-43. PubMed ID: 31982106
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1).
    Lastoria S, Marciello F, Faggiano A, Aloj L, Caracò C, Aurilio M, D'Ambrosio L, Di Gennaro F, Ramundo V, Camera L, De Luca L, Fonti R, Napolitano V, Colao A.
    Endocrine; 2016 Jun 07; 52(3):488-94. PubMed ID: 26242621
    [Abstract] [Full Text] [Related]

  • 14. Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.
    Gonçalves TD, Toledo RA, Sekiya T, Matuguma SE, Maluf Filho F, Rocha MS, Siqueira SA, Glezer A, Bronstein MD, Pereira MA, Jureidini R, Bacchella T, Machado MC, Toledo SP, Lourenço DM.
    J Clin Endocrinol Metab; 2014 Jan 07; 99(1):E89-96. PubMed ID: 24178797
    [Abstract] [Full Text] [Related]

  • 15. Preoperative assessment of the pancreas in multiple endocrine neoplasia type 1.
    Lewis MA, Thompson GB, Young WF.
    World J Surg; 2012 Jun 07; 36(6):1375-81. PubMed ID: 22382771
    [Abstract] [Full Text] [Related]

  • 16. Prospective evaluation of imaging procedures for the detection of pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.
    Langer P, Kann PH, Fendrich V, Richter G, Diehl S, Rothmund M, Bartsch DK.
    World J Surg; 2004 Dec 07; 28(12):1317-22. PubMed ID: 15517479
    [Abstract] [Full Text] [Related]

  • 17. Pancreatic imaging in MEN1-comparison of conventional and somatostatin receptor positron emission tomography/computed tomography imaging in real-life setting.
    Kostiainen I, Majala S, Schildt J, Parviainen H, Kauhanen S, Seppänen H, Miettinen PJ, Matikainen N, Ryhänen EM, Schalin-Jäntti C.
    Eur J Endocrinol; 2023 May 10; 188(5):421-429. PubMed ID: 36943311
    [Abstract] [Full Text] [Related]

  • 18. What is the appropriate management of nonfunctioning pancreatic neuroendocrine tumours disclosed on screening in adult patients with multiple endocrine neoplasia type 1?
    Challis BG, Casey RT, Grossman A, Newell-Price J, Newey P, Thakker RV.
    Clin Endocrinol (Oxf); 2019 Dec 10; 91(6):708-715. PubMed ID: 31505044
    [Abstract] [Full Text] [Related]

  • 19. EUS is still superior to multidetector computerized tomography for detection of pancreatic neuroendocrine tumors.
    Khashab MA, Yong E, Lennon AM, Shin EJ, Amateau S, Hruban RH, Olino K, Giday S, Fishman EK, Wolfgang CL, Edil BH, Makary M, Canto MI.
    Gastrointest Endosc; 2011 Apr 10; 73(4):691-6. PubMed ID: 21067742
    [Abstract] [Full Text] [Related]

  • 20. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
    Beiderwellen KJ, Poeppel TD, Hartung-Knemeyer V, Buchbender C, Kuehl H, Bockisch A, Lauenstein TC.
    Invest Radiol; 2013 May 10; 48(5):273-9. PubMed ID: 23493121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.